Cargando…
Comprehensive Analysis of IGFBPs as Biomarkers in Gastric Cancer
OBJECTIVE: Gastric cancer is the fifth most common cancer worldwide and the third leading cause of cancer-related deaths. Insulin-like growth-factor-binding proteins (IGFBPs) were initially identified as passive inhibitors that combined with insulin-like growth factors (IGFs) in serum. However, more...
Autores principales: | Liu, Qi, Jiang, Jianwu, Zhang, Xiefu, Zhang, Meixiang, Fu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567138/ https://www.ncbi.nlm.nih.gov/pubmed/34745945 http://dx.doi.org/10.3389/fonc.2021.723131 |
Ejemplares similares
-
Insulin Growth Factor Binding Protein 7 (IGFBP7)-Related Cancer and IGFBP3 and IGFBP7 Crosstalk
por: Jin, Li, et al.
Publicado: (2020) -
Comprehensive analysis of the prognostic value and immune infiltration of FGFR family members in gastric cancer
por: Yang, Chengcheng, et al.
Publicado: (2022) -
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence: A Nested Case-Control Study
por: Rosendahl, Ann H., et al.
Publicado: (2021) -
Comprehensive Analysis of Immune Implications and Prognostic Value of SPI1 in Gastric Cancer
por: Huang, Jianfeng, et al.
Publicado: (2022) -
XBP1- IGFBP3 Signaling Pathway Promotes NSCLC Invasion and Metastasis
por: Luo, Qingxi, et al.
Publicado: (2021)